Background Reliable and timely information on the leading causes of death in populations,
and how these are changing, is a crucial input into health policy debates. In the Global …

Background Epidemiologic studies of the prevalence of rheumatic heart disease have used
clinical screening with echocardiographic confirmation of suspected cases. We …

Over the past 5 years, the advent of echocardiographic screening for rheumatic heart disease
(RHD) has revealed a higher RHD burden than previously thought. In light of this global …

Aims Rheumatic heart disease (RHD) accounts for over a million premature deaths annually;
however, there is little contemporary information on presentation, complications, and …

“As we embark on this great collective journey, we pledge that no one will be left behind.
Recognizing that the dignity of the human person is fundamental, we wish to see the goals and …

Background Rheumatic heart disease affects more than 40.5 million people worldwide and
results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart …

From a global perspective, the large and diverse African population is disproportionately
affected by cardiovascular disease (CVD). The historical balance between communicable and …

Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan
Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, …

Background: There are few contemporary data on the mortality and morbidity associated
with rheumatic heart disease or information on their predictors. We report the 2-year follow-up …

Background Endomyocardial fibrosis is the most common restrictive cardiomyopathy worldwide.
It has no specific treatment and carries a poor prognosis, since most patients present …